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Abstract
Background—Adipose tissue (AT) is the body’s largest free cholesterol (FC) reservoir and
abundantly expresses ATP binding cassette transporter A1 (ABCA1), a key cholesterol transporter
for HDL biogenesis. However, the extent to which AT ABCA1 expression contributes to HDL
biogenesis in vivo is unknown.
Methods and Results—Adipocyte-specific ABCA1 knockout mice (ABCA1−A/−A) were
generated by crossing ABCA1floxed mice with aP2 cre transgenic mice. AT from ABCA1−A/−A
mice had <10% of wild type (WT) ABCA1 protein expression, but normal hepatic and intestinal
expression. Deletion of adipocyte ABCA1 resulted in a significant decrease in plasma HDL
cholesterol (~15%) and apoA-I (~13%) concentrations. AT from ABCA1−A/−A mice had a two-
fold increase in FC content, compared to WT mice, and failed to efflux cholesterol to apoA-I.
However, cholesterol efflux from AT to plasma HDL was similar for both genotypes of mice.
Incubation of WT AT explants with apoA-I resulted in formation of multiple discrete-sized
nascent HDL particles ranging in diameter from 7.1–12 nm; similar incubations with
ABCA1−A/−A AT explants resulted in nascent HDL <8 nm. Plasma decay and tissue uptake of
WT 125I-HDL tracer was similar in both genotypes of recipient mice, suggesting that adipocyte
ABCA1 deficiency reduces plasma HDL concentrations solely by reducing nascent HDL particle
formation.
Conclusions—We provide in vivo evidence that AT ABCA1-dependent cholesterol efflux and
nascent HDL particle formation contribute to systemic HDL biogenesis and that AT ABCA1
expression plays an important role in adipocyte cholesterol homeostasis.
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Adipose tissue (AT) represents 10–35% of total body mass in humans 1 and plays a central
role in integrating energy metabolism and glucose homeostasis 2. Although AT is the major
site of fatty acid storage as triglyceride, it is also the body’s largest free cholesterol (FC)
reservoir 3. Due to the lack of acyl-coenzyme A:cholesterol acetyltransferase (ACAT)
enzyme activity in AT, nearly all cholesterol (>95%) exists as FC 4 and resides in the
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plasma membrane or at the cytosolic interface of lipid droplets 5. There is accumulating
evidence that adipose cholesterol imbalance is closely associated with adipocyte dysfunction
and obesity-mediated metabolic complications, including low levels of HDL cholesterol and
insulin resistance 6, 7. Therefore, FC efflux from AT is likely to influence whole body
cholesterol metabolism and homeostasis. However, the pathways by which FC exits from
AT and its potential impact on plasma high density lipoprotein (HDL) cholesterol levels
have not been fully investigated.
ATP-binding cassette transporter A1 (ABCA1) is an essential membrane protein for the
initial step of HDL biogenesis by facilitating the efflux of cellular FC and phospholipid to
extracellular lipid-free apolipoprotein A-I (apoA-I), forming nascent HDL particles 8. Loss
of functional mutations in ABCA1 results in Tangier disease, with <5% the normal
concentration of plasma HDL 9. Using human embryonic kidney (HEK)-293 cells stably
overexpressing ABCA1, we previously demonstrated that ABCA1 expression in a non-
hepatic cell line is necessary and sufficient to produce distinct, heterogeneous-sized nascent
HDLs, ranging in diameter from 7–12 nm, which subsequently undergo intravascular
metabolism to become mature HDL in plasma 10–12. Although ABCA1 is expressed to
varying degrees in many different cell types13, not all ABCA1-expressing cells equally
contribute in vivo to plasma HDL formation. For example, macrophage ABCA1 expression
is abundant, but it has no significant impact on plasma HDL levels 14. On the other hand,
hepatic and intestinal ABCA1 expression is estimated to contribute 70–80% and 15–20% of
the plasma HDL pool, respectively 15, 16. Intriguingly, deletion of both hepatic and intestinal
ABCA1 resulted in ~90% reduction in plasma HDL 16, whereas global ABCA1 knockout
mice have <5% of normal levels of HDL cholesterol, similar to subjects with Tangier
disease 9. These results suggest that ABCA1 expression in cells other than hepatocytes and
intestinal epithelial cells would minimally affect plasma HDL formation. However, formal
testing of a cell type’s contribution to the plasma HDL pool requires specific deletion of
ABCA1 in that cell.
AT is a major storage pool of FC, which expands during obesity, and abundantly expresses
ABCA1, but the role of adipocyte ABCA1 expression in FC efflux and HDL formation in
vivo is unknown 3, 7, 17. AT has been proposed as important in plasma HDL production
based on indirect evidence, such as an inverse association between adipose cholesterol
content and plasma cholesterol concentrations 3. A recent study provided in vivo evidence
that adipocytes support the transfer of FC to plasma HDL 17. In that study, mouse
embryonic fibroblasts (from WT, ABCA1 KO, and SR-BI KO mice) were differentiated into
adipocytes, radiolabeled with 3H-cholesterol, and injected into the peritoneal cavity of mice.
Reverse cholesterol transport of 3H-cholesterol from adipocytes to the feces depended on
adipocyte expression of ABCA1 and SR-BI 17. However, direct in vivo evidence for the role
of adipose ABCA1 in plasma HDL formation remains lacking, and the extent to which
adipose ABCA1 expression contributes to plasma HDL, particularly in the obese state, has
not been investigated.
The purpose of this study was to directly test the role of adipocyte ABCA1 in the formation
of nascent HDL particles and its contribution to the plasma HDL pool in vivo. To
accomplish this, we generated adipocyte-specific ABCA1 knockout (ABCA1−A/−A) mice
and investigated their plasma lipid and lipoprotein phenotypes during chow and high fat
(HF) diet feeding. We also determined the role of ABCA1 in adipocyte cholesterol
homeostasis and nascent HDL particle formation using AT explants from these mice. Our
results suggest a significant role for AT ABCA1 expression in nascent HDL particle
formation and AT cholesterol homeostasis.
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Methods
Animals
Adipocyte specific ABCA1 knockout mice (ABCA1−A/−A) were generated by crossing
ABCA1floxed mouse 15 (backcrossed into the >99% C57BL/6 background) with fatty acid
binding protein 4 (FABP4; aP2) Cre transgenic mouse (Jackson Laboratories). For all
experiments, 10- to 16-wk-old male mice were used. To expand AT mass, mice were
switched from a commercial chow diet at 8 wks of age to a commercial HF diet (42% Cal
from fat, 0.2% cholesterol; TD 88137, Harlan™) for an additional 8–16 wks, depending on
the experiment. The mice were housed in the Wake Forest University Health Sciences
animal care facilities with a 12 h light/12 h dark cycle. All protocols and procedures were
approved by the Wake Forest University Health Sciences Animal Care and Use Committee.
Plasma cholesterol determination and FPLC
Plasma was collected by tail bleeding of mice fasted for 4 h. Plasma from 4 mice was pooled
and size fractionated by FPLC using a Superose 6 TM column (Amersham Biosciences).
Plasma cholesterol was determined using an enzymatic colorimetric assay kit (Roche
Applied Science).
qPCR and Western blot analysis
Total RNA was extracted by Trizol (Invitrogen) according to the manufacturer’s protocol.
cDNA preparation and qPCR were conducted as described previously 14. To prepare tissue
lysate, ~0.1 g of snap frozen tissue was homogenized in RIPA buffer. For AT, the lysate was
incubated on ice for 10 min to remove the solidified fat cake on top. Immunoblotting of
ABCA1 was conducted as previously described using 4–16% SDS-PAGE 15. Monoclonal
antibodies directed against PPARγ and GAPDH were purchased from Sigma. Polyclonal
antibodies against apoE, apoA-I (Biodesign), and anti-SRB-I (Novartis) were also used for
Western blotting.
Adipose cholesterol determination
AT cholesterol was determined by gas liquid chromatography (GLC) after extraction of total
lipid from 0.1 g of AT with chloroform:methanol (2:1) 14. Data were normalized to tissue
wet weight or protein, measured by the Lowry assay 18.
Preparation of ex vivo cultures of AT
To establish the ex vivo cultures of AT, freshly isolated epididymal fat (0.1~0.2 g) was
minced into ~2 mm pieces, moved into 10 cm cell culture dishes, and incubated overnight in
1.5 ml of serum-free DMEM F/12 Ham (Sigma). The next day, AT cultures were washed
thoroughly with caution to remove floating cells without aspirating the minced tissue
explants.
Cholesterol efflux from AT
Measurement of cholesterol efflux was conducted according to standard methods, except ex
vivo AT cultures were used 17, 19. Briefly, ex vivo cultures of AT (pooled from n=4 mice per
genotype; n=4 replicates) were incubated with 5 μCi of [3H]-cholesterol (complexed to
BSA) for 24 h. AT explants were then washed carefully and 1 ml of fresh serum-free
medium was added. Cholesterol efflux was initiated by adding either 20 μg protein/ml of
human apoA-I (ABCA1-dependent efflux) or 50 μg protein/ml of mouse HDL (ABCA1-
independent efflux) as acceptors. After 4 h of additional incubation, cholesterol efflux was
quantified by measuring [3H]-cholesterol in 500 μl of medium and in the cells, after
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isopropanol extraction. Percentage efflux was calculated as dpm [3H]-cholesterol in
medium/(medium + cells) times 100%.
Nascent HDL formation
All the procedures for nascent formation were similar to our previous study 20. Briefly, 10
μg/ml of lipid-free [125I]-apoA-I (105 cpm/μg) was incubated with AT explants for 24 h.
One ml of conditioned medium was then fractionated by high resolution fast protein liquid
chromatography size-exclusion chromatography using three Superdex 200 HR columns in
series. 125I radioactivity in each fraction was quantified using a gamma counter (Beckman).
Electrophoretic mobility of adipose-derived nascent HDLs was analyzed using a Paragon
lipoprotein agarose gel electrophoresis system (Beckman) according to the manufacturer’s
instructions. Electrophoretic mobilities (α, β, preβ) were determined after lipid staining of
plasma from LDLr knockout mice. The size distribution of nascent HDL particles in
conditioned medium was also determined on a 4–30% non-denaturating gradient gel
(NDGGE) as described previously20.
HDL catabolism and tissue specific uptake
125I-radiolabeled tyramine cellobiose (TC)-HDL ([125I]-TC-HDL) was prepared as
previously described except HDL was isolated from wild type (WT) mouse plasma 15, 21.
Recipient mice (n=4 per genotype) were anesthetized with isoflurane and [125I]-TC-HDL
(500,000 cpm/animal) was injected via a jugular vein catheter. Blood samples (~30μl) were
drawn at 5 min, 30 min, and 1, 3, 6 and 24 h after tracer injection by retro-orbital bleeding,
and 15μl of plasma were used for quantification of [125I] radioactivity. Data were expressed
as a percentage of the 5 min plasma radioactivity remaining in plasma after injection of the
tracer. The plasma die-away curves were generated using a bi-exponential curve-fitting
program (GraphPad Prism 5). For the determination of tissue-specific uptake of HDL, mice
were sacrificed 24 h after [125I]-TC-HDL injection and liver, kidney and epididymal fat pads
were removed to quantify 125I radioactivity.
Statistics
Results are presented as mean ± standard error of the mean. Data were statistically analyzed
using multiple tests. A general linear regression model was used to assess relationships
between FC and ABCA1 within and across fat depots while controlling for intra-animal
correlations. A Student’s t test was used to test for differences in adipose tissue ABCA1
expression and radiolabeled HDL tracer tissue uptake between wild type and ABCA1−A/−A
mice. For comparison of variables (i.e., total plasma cholesterol, epididymal fat cholesterol
content) among all three genotypes of mice or more than two treatments (cholesterol efflux),
one-way analysis of variance, followed by Tukey’s multiple comparison test to identify
individual group differences was used. Two-way ANOVA with repeat measures (0–16 week
time course) was used to compare total plasma cholesterol concentrations during HF diet
feeding between WT and ABCA1−A/−A mice. Statistical tests were performed using
GraphPad software (San Diego, CA) or SAS software.
Results
ABCA1 expression varies among fat depots
AT exhibits regional heterogeneity with regard to cellular composition, response to
hormonal signals, and metabolic function22. To gain insight into the role of fat depot-
specific cholesterol regulation by ABCA1, C57BL/6 mice (n=3) were fed a high fat (HF/
HC)-diet (42% fat and 0.2% cholesterol) to increase fat mass. After the mice had consumed
the diet for 8 wks, we measured cholesterol content by gas-liquid chromatography (GLC)
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and relative ABCA1 expression by Western blot in different fat depots. There was a sixfold
variation in FC content (no detectable cholesteryl ester) among fat depots (epididymal >
mesenteric > pericardial ≈ inguinal (subcutaneous) > brown fat). ABCA1 expression was
equally variable among depots, with a strongly positive correlation (r2=0.34; 0.01) between
fat depot FC content and ABCA1 expression, but not SR-BI or apoE expression (Fig 1A, B).
Next, we examined AT ABCA1 expression using epididymal fat depots from C57BL/6
mice. There are conflicting results in the literature regarding the extent to which 3T3-L1
fibroblasts express ABCA1 before they are differentiated into adipocytes 17, 19. To
determine whether ABCA1 is expressed in non-adipocyte cells residing in AT, stromal
vascular (SV) cells were fractionated from floating mature adipocytes using methods
previously described 23. ABCA1 expression was almost exclusively confined to adipocytes,
with little expression in SV cells (Fig 1C). To establish a primary adipocyte culture system
from mouse AT, isolated SV cells were incubated with a differentiation cocktail 23. After 10
days, ~60% of cells were converted into lipid-laden adipocytes by oil red-O staining (Suppl.
Fig 1A). ABCA1 expression levels were also increased during adipogenesis (Fig 1D). To
determine the cellular localization of ABCA1, adipocyte cultures were immunostained with
ABCA1 monoclonal antibody. ABCA1 staining was observed in the plasma membrane and
cytosol of adipocytes, suggesting that ABCA1 may traffic between the plasma membrane
and cytosol (Suppl Fig 1B).
Adipose tissue generates nascent HDL particles of multiple sizes
ABCA1-dependent FC efflux has been reported for 3T3-L1 adipocytes 19, 24 and mouse
embryonic fibroblast derived-adipocytes 17. However, ABCA1-dependent nascent HDL
particle formation by unilocular adipocytes in AT has not been investigated. Thus, we
established ex vivo cultures of mouse epididymal AT and incubated the freshly-isolated AT
explants with 125I-apoA-I for 24 h, after which nascent HDL subpopulations in the
conditioned medium were size-fractionated by high resolution FPLC 10, 11. Consistent with
our previous studies using HEK293 cells stably expressing human ABCA1 10, 11, AT from
C57BL/6 mice generated heterogeneously-sized nascent HDL particles that migrated in the
pre-β position on agarose gels (Fig 1E). More importantly, the size distribution of nascent
HDL species from AT followed a similar pattern as that from HEK293-ABCA1 expressing
cells (Fig 1F) as well as mouse peritoneal macrophages and McArdle 7777 hepatoma
cells 11, with five distinct subfractions ranging in size from 7–17 nm in diameter.
Deletion of adipocyte ABCA1 decreases plasma HDL levels
To investigate the role of adipocyte ABCA1 in AT cholesterol mobilization and its impact
on HDL plasma level in vivo, we generated adipocyte-specific ABCA1 knockout mice
(ABCA1−A/−A). Adipocyte-specific ABCA1 inactivation was achieved by crossing C57BL/
6 ABCA1flox/flox mice with aP2 (fatty acid binding protein 4)-Cre transgenic mice
backcrossed in the C57BL/6 background (Jackson Labs). ABCA1−A/−A mice were fertile
and pups were born at the expected Mendelian frequency. Recombination of the floxed
ABCA1 allele resulted in >90% decrease in ABCA1 protein expression in ABCA1−A/−A
mouse epididymal fat and 87% reduction of ABCA1 mRNA in epididymal fat (Fig 2A).
Inactivation of adipose ABCA1 had little effect on ABCA1 expression in liver and intestine,
which are the main organs known to be important for HDL biogenesis (Fig 2B). However,
ABCA1 expression was noticeably reduced in resident peritoneal macrophages (Fig 2C),
thioglycolate-elicited macrophages (Fig 2D), and, to a lesser extent, in bone marrow-derived
macrophages (Fig 2C). ABCA1 expression in WT epididymal and mesenteric AT was
abundant and comparable to that in liver and macrophages, but its expression was marked
blunted in ABCA1−A/−A mouse epididymal, brown and mesenteric fat (Figure 2D). Thus,
deletion of ABCA1 expression was highly efficient in AT and somewhat variable in
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macrophages. However, macrophage ABCA1 expression has minimal impact on plasma
HDL levels 14, 25–27, so we proceeded with studies on the role of adipocyte ABCA1
expression on HDL metabolism and adipocyte cholesterol balance.
Next, we evaluated the contribution of adipose ABCA1 expression on plasma cholesterol
concentrations and distribution using WT and ABCA1−A/−A mice consuming chow or a HF
diet. There was step-wise reduction in total plasma cholesterol with successive deletion of
ABCA1 alleles (Figure 3A: WT, 83 ± 3; heterozygotes, 70 ± 6; homozygotes, 62 ± 4 mg/dl,
respectively) that reached statistical significance for male WT vs. ABCA1−A/−A mice
(p<0.0084 by ANOVA with Tukey’s post hoc test). In addition, Western blot analysis of
plasma suggested a reduction in apoA-I (KO/WT ratio= 0.72) and apoE (KO/WT ratio=
0.86) concentration, but not LCAT (KO/WT ratio= 1.03) (Figure 3B). The lower plasma
cholesterol levels for ABCA1−A/−A mice persisted throughout the 16 wks of HF-diet (2-way
ANOVA with repeated measures; time effect, p<0.0001, genotype effect, p<0.001; n=4
each), suggesting that deletion of adipose ABCA1 results in decreased plasma cholesterol
pool size despite expanding AT mass (Figure 3C). FPLC fractionation of plasma revealed
that the decreased plasma cholesterol in ABCA1−A/−A mice was mainly in the HDL region
of the column (Figure 3D). These data provide evidence that AT ABCA1 expression
contributes a small, but significant, fraction of the plasma HDL pool.
To exclude the possibility that decreased plasma HDL concentration in ABCA1−A/−A mice
was due to increased hepatic uptake and degradation of HDL, we measured plasma
clearance and tissue uptake of HDL apoA-I. Because HDL from WT and ABCA1−A/−A
mice was similar in chemical composition (data not shown), HDL was isolated from plasma
of WT mice and radiolabeled with tyramine cellobiose (TC), a tissue residualizing
compound that allows quantification of tissue uptake of radiolabeled tracer during turnover
studies 15, 21. The plasma removal of [125I]-TC-HDL tracer in ABCA1−A/−A mice was
indistinguishable from that of WT mice over the 24 h turnover study (Figure 4A). There also
was no difference in tissue uptake of HDL tracer by liver, kidney or AT (Figure 4B),
indicating that selective inactivation of adipocyte ABCA1 did not affect HDL catabolism in
vivo. These results suggested that the decreased plasma HDL levels in ABCA1−A/−A mice
were due to decreased HDL production by adipose tissue.
Deletion of adipocyte ABCA1 blunted ABCA1-dependent cholesterol efflux and large
nascent HDL formation in adipose tissue
To determine whether deletion of ABCA1 in adipocytes resulted in increased FC content,
similar to what we observed in macrophages from macrophage-specific ABCA1 knockout
mice 14, we measured TC and FC in epididymal and brown fat from 3–4 mice after 16 wks
of HF/HC diet feeding. There was a gene dose-related increase in FC content (p<0.001) in
epididymal fat that reached statistical significance in ABCA1−A/−A mice (Figure 5A). CE
was low to undetectable in the samples (data not shown). These results suggested that FC
efflux from adipose explants was severely compromised in the absence of functional
ABCA1. To address this question, we incubated AT explants from chow-fed mice with 3H-
cholesterol for 24 h to radiolabel the cells, washed the cells, and incubated them for 4 h with
apoA-I (20μg/ml) to measure ABCA1-dependent efflux, or with HDL (50 μg/ml) to measure
ABCA1-independent efflux. ABCA1-dependent 3H-FC efflux to apoA-I was completely
eliminated in ABCA1−A/−A epididymal fat compared with WT. However, HDL-mediated
FC efflux (ABCA1-independent) was unaffected by deletion of adipose ABCA1 expression
(Figure 5B). To determine whether the ablation of ABCA1-dependent efflux to apoA-I in
ABCA1−A/−A epididymal fat was accompanied by loss of nascent HDL formation, we
incubated [125I]-apoA-I with ex vivo cultures of WT or ABCA1−A/−A epididymal fat and
monitored nascent HDL formation by non-denaturating gradient gel electrophoresis and
high resolution FPLC (Figure 5C). WT epididymal fat generated multiple, heterogeneous-
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sized HDL subfractions that ranged in size from 7–12 nm diameter, which we have
designated as preβ 1–5 in order of increasing particle size. We have also observed similar
nascent HDL particle size heterogeneity in cultures of HEK293 cells stably expressing
ABCA1, mouse peritoneal macrophages, and rat McArdle 7777 hepatoma cells 11, 20. In
contrast, epididymal fat from ABCA1−A/−A mice generated only particles <10 nm in
diameter (i.e., preβ 2).
Discussion
This study was designed to elucidate the role of adipocyte ABCA1 expression in nascent
HDL particle formation and its contribution to the plasma HDL pool in vivo. To address this
issue, we generated ABCA1−A/−A mice and studied them while they were consuming a
chow or HF diet. Several novel observations were made in this study. First, AT ABCA1
expression varied over a five-fold range among different fat depots in C57BL/6 mice and
was significantly associated with FC content among different adipose tissues, suggesting an
important role for ABCA1 expression in AT sterol homeostasis. Second, ABCA1−A/−A mice
had <10% expression of ABCA1 protein in AT compared to WT mice, with a concomitant
two-fold increase in AT cholesterol content. Although FC efflux from AT explants to HDL
was similar between WT and ABCA1−A/−A mice, FC efflux to apoA-I was eliminated in
ABCA1−A/−A AT, suggesting an important and specific role for ABCA1 in AT FC
homeostasis. Third, WT AT explants were capable of generating multiple, discrete-sized
nascent HDL subfractions from apoA-I, ranging in diameter from 7–12 nm, similar to other
cell types. However, ABCA1−A/−A AT generated nascent HDL particles <10 nm, suggesting
a considerable loss of function in the ability to generate nascent HDL. The decreased ability
to generate nascent HDL was reflected in vivo as a 15% reduction in plasma HDL
concentration in ABCA1−A/−A vs. WT mice that was attributed to HDL production, since
HDL catabolism was similar between the two genotypes of mice. Collectively, these results
establish a novel role for adipocyte ABCA1 in AT cholesterol mobilization and cholesterol
balance and in vivo HDL production.
AT is the main depot for triglyceride and is used to meet systemic energy needs 3. It is also
the body’s largest cholesterol storage depot; uniquely, >95% of AT cholesterol is FC, due to
low esterification activity by ACAT 3. As adipocytes expand in size during obesity, FC and
lipid droplet FC increase 3, but plasma membrane FC decreases 28. This redistribution of FC
increases plasma membrane fluidity, decreases insulin signaling, and increases adipocyte
cholesterol biosynthesis 28. Thus, maintaining the optimal amount and intracellular
distribution of FC in adipocytes appears functionally important in AT. Since cholesterol
biosynthesis is relatively low in AT 29, FC efflux may be an important regulator of sterol
homeostasis. Recent studies indicate that ABCA1 and SR-BI are important regulators of
cholesterol efflux from adipocytes 17. Initially, adipocytes were thought to have low ABCA1
expression 13, but subsequent studies using 3T3L1 adipocytes 17, 28, adipose tissue 30, and
our data in isolated adipocytes (Figure 1C, D) demonstrate that ABCA1 is abundantly
expressed. Furthermore, we observed that ABCA1 expression varies over a five-fold range
among AT depots and that this variation is highly correlated with AT FC content (Figure
1A, B). These data suggest that as metabolically active visceral fat stores enlarge during TG
accretion, FC also increases; this in turn upregulates expression of ABCA1 to rebalance
cellular cholesterol homeostasis. ABCA1 gene transcription is highly regulated by liver X
receptor expression in some tissues 31, 32, but whether this pathway is responsible for
variable ABCA1 protein expression among AT depot sites is unknown. Nevertheless, these
data establish a critical association between AT ABCA1 expression and FC content, which
may be important in the modulation of adipocyte metabolic activity.
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To determine the role of AT ABCA1 expression on plasma HDL concentrations, we
generated ABCA1−A/−A mice by crossing ABCA1flox/flox mice with aP2 Cre recombinase
transgenic mice. ABCA1 protein expression in epididymal fat decreased in proportion to the
number of inactivated ABCA1 alleles (Figure 1A). Recombination of the ABCA1 gene was
efficient in all AT depots examined, with >90% elimination of ABCA1 protein expression in
ABCA1−A/−A mice. Expression of SR-BI, another protein important in adipocyte FC
efflux 17, was unaffected (Figure 1D). ABCA1−A/−A mice had lower plasma total and HDL
cholesterol concentrations compared to WT mice, whether they were fed chow or a HF diet
(Figure 3C, D). To determine whether this phenotype was due directly to deletion of AT
ABCA1 or indirectly due to changes in ABCA1 expression in other tissues, specificity of the
recombination was investigated. ABCA1 expression in liver and intestine, two tissues
previously shown to be important in determining plasma HDL concentrations 15, 16, was
similar in WT vs. ABCA1−A/−A mice and could not account for the differences in plasma
HDL concentrations. aP2 Cre recombinase has been reported to be active in macrophages 33,
so we also examined ABCA1 expression in resident, elicited peritoneal, and bone marrow-
derived macrophages. ABCA1 expression was variably reduced in macrophages from
ABCA1−A/−A mice, confirming previous results that aP2 Cre recombinase was active in
macrophages 34. However, evidence from our lab 14 and others 25–27 using transplantation of
total ABCA1 knockout bone marrow has demonstrated that macrophage ABCA1 expression
has no significant impact on plasma HDL concentrations. Taken together, these data suggest
that AT ABCA1 expression plays a significant role in determining plasma HDL
concentrations.
Although our data suggested that HDL production by AT was reduced in the absence of
adipocyte ABCA1 expression, deletion of adipocyte ABCA1 may have indirectly increased
HDL catabolism, resulting in reduced plasma HDL levels. Previous studies in humans
suggest that HDL catabolism plays an important role in determining plasma HDL
concentrations 35. To formally examine this possibility, we performed HDL turnover studies
using radiolabeled WT HDL, since HDL composition was similar between WT and
ABCA1−A/−A mice (data not shown). Plasma decay of the HDL tracer and uptake of
radiolabel by the liver and kidney, the two most important tissues in HDL protein uptake
and catabolism 15, 21, was similar for both genotypes of mice (Figure 4). Based on these
data, we conclude that decreased plasma HDL concentrations in ABCA1−A/−A mice were
due to decreased HDL production by AT, relative to WT mice, and not to differences in
HDL catabolism.
Although our study as well as others 17 implicate AT in HDL production, direct evidence for
the assembly of nascent HDL particles by AT has not been demonstrated. In this study, we
show that epididymal fat from ABCA1−A/−A mice had a doubling of FC content, was
defective in FC efflux to apoA-I, and was defective in production of nascent HDL particles
>10 nm in diameter (Figure 5). Zhang et al 17 have shown that both ABCA1 and SR-BI, but
not ABCG1, are important for FC efflux from adipocytes, differentiated from mouse
embryonic fibroblasts. Our study confirms and extends their results by showing that ABCA1
is critical for maintaining FC content and efflux to ABCA1 in primary AT explants.
Furthermore, the two-fold increase in AT FC content suggests that SR-BI cannot
compensate for the loss of ABCA1 expression. This was confirmed by the similar
expression of SR-BI among AT depots in WT and ABCA1−A/−A mice (Figure 2D).
Previous studies have shown that ectopic expression of ABCA1 in cell lines is necessary and
sufficient to generate several discrete-sized nascent HDL particles 10. We have designated
these particles as preβ 1–5 on the basis of increasing particle size on non-denaturing gradient
gels and FPLC columns and mobility on agarose or two-dimensional gels. These nascent
preβ HDL particles appear to be formed simultaneously in cell culture systems, with no
evidence for a precursor-product dependency (i.e., small particles → larger
Chung et al. Page 8
Circulation. Author manuscript; available in PMC 2012 October 11.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
particles) 10, 36–38. Similar discrete, nascent HDL particle sizes have previously been
observed for McArdle 7777 hepatoma cells, mouse peritoneal macrophages 11, and primary
hepatocytes (unpublished data), in addition to transfected cell lines, suggesting that ABCA1
expression is the necessary and sufficient condition for nascent HDL size heterogeneity
among these varied cell types. Epididymal fat explants from WT mice also generated
nascent HDL particles with apoA-I that were strikingly similar in size to those reported for
other cell culture systems (Figure 1F). However, epididymal fat explants from ABCA1−A/−A
mice did not generate nascent HDL >10 nm (Figure 5C). We speculate that the formation of
preβ 2 HDL resulted from the residual (<10%) ABCA1 protein expression in AT of
ABCA1−A/−A mice (Figure 2D). Support for this idea comes from a study in which siRNA
silencing of ABCA1 in McArdle 7777 hepatoma cells resulted in ~70–80% reduction of
ABCA1 protein expression and decreased formation of nascent HDL >10 nm 20. Overall,
our studies provide evidence that AT ABCA1 expression directly contributes to the
formation of multiple, discrete-sized nascent HDL particles.
Obesity is associated with chronic low-grade inflammation, adipocyte dysfunction (i.e.,
adipokine secretion, impaired lipolysis, insulin resistance), and low plasma HDL 39.
Adipocyte ABCA1 expression may represent a compensatory mechanism to limit
inflammation and adipocyte dysfunction that accompanies obesity and metabolic syndrome.
Since adipocyte FC content increases with obesity and adipocyte hypertrophy, we speculate
that ABCA1 is upregulated in adipocytes to maintain optimal FC balance between the lipid
droplet and plasma membrane, and adipocyte function. With development of obesity,
accretion of FC during adipocyte expansion may sequester FC on lipid droplets, shunting it
away from ABCA1-mediated HDL particle formation, resulting in decreased plasma HDL
concentrations. In contrast, rapid weight loss may result in FC mobilization to the adipocyte
plasma membrane, resulting in increased ABCA1-mediated HDL particle formation, and
increased plasma HDL concentrations. Thus, adipocyte ABCA1 may be a critical negative
regulator of obesity and metabolic syndrome, preventing adipocyte dysfunction and
abnormal plasma membrane FC accumulation by facilitating FC efflux and nascent HDL
formation.
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Figure 1. Adipocytes abundantly express ABCA1 and efficiently produce nascent HDL particles
A. ABCA1, SR-BI, and apoE protein expression by Western blot analysis in different fat
depots after 8 wks of HF diet in C57BL/6 mice (n=2 for each depot). GAPDH was used as a
load control. B. Association between ABCA1 expression and FC content among six fat
depots in C57BL/6 mice fed a HF diet for 8 wks (n=3 mice for each depot). Across depots,
the line of best fit (r2=0.34), determined by regression analysis for all data points controlling
for intra-animal correlations, is shown (p<0.01). Within depots, the overall association did
not reached statistical significance due to one outlier value in retrorenal fat. C. ABCA1
expression in adipose tissue (AT), adipocytes (Adi), and stromal vascular (SV) cells.
Collagenase-treated epididymal fat was fractionated into floating adipocytes (Adi) and
pelleted stromal vascular cells (SV) for Western blot analysis of ABCA1 and aP2
expression. β-actin was used as a load control. D. ABCA1 expression at 0, 3, and 10 days
after differentiation of SV cells into adipocytes. β-actin was used as a load control. E.
Electrophoretic mobility of [125I]-apoA-I and conditioned medium from epididymal fat
tissue (Epi Fat) incubated with [125I]-apoA-I for 24 hr on a Paragon lipoprotein agarose gel
electrophoresis system. After electrophoresis, [125I]-apoA-I mobility was visualize using a
phosphorimager. α, preβ and β positions on the gel are shown for reference. F. Nascent HDL
formation from epididymal tissue explants. [125I]-apoA-I was incubated with either
HEK293-ABCA1 cells (■) or 0.2 g of epididymal fat explants (○) for 24 h. Conditioned
medium was then fractionated by high resolution FPLC and radiolabel in each fraction
determined by gamma counting. Nascent HDL particles of increasing size are designated as
preβ 1–5 based on previous studies. Elution position of [125I]-apoA-I is shown for reference.
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Figure 2. Tissue-specific expression of ABCA1 in adipocyte-specific ABCA1 knockout mice
A. ABCA1 expression in epididymal AT from WT (+/+), heterozygous (−A/+), and
homozygous (−A/−A) ABCA1 knockout mice. Left panel: Western blot analysis of
ABCA1, PPARγ 2 expression. ns=non-specific band. Right panel: mRNA expression of
ABCA1 normalized to cyclophilin, determined by quantitative real time PCR. Mean ± SEM
(n=3). B. Western blot analysis of hepatic and intestinal ABCA1 expression. ***=p<0.001.
C. Western blot analysis of macrophage ABCA1 expression in resident peritoneal and bone
marrow-derived macrophages (Mφ). D. Relative expression of ABCA1, aP2, and SR-BI in
different tissues (i.e., liver, thioglycolate-elicited peritoneal macrophages, and 3 fat depots)
of WT and ABCA11A/−A mice. Male mice were used in all assays and each lane represents
for individual mouse. GAPDH was used as a load control in each blot.
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Figure 3. Deletion of adipocyte ABCA1 reduces plasma cholesterol and HDL concentration
A. Total plasma cholesterol levels of chow-fed WT (+/+), heterozygous (−A/+) and
homozygous (−A/−A) adipocyte-specific ABCA1 knockout mice. B. Plasma levels of
apoA-I, apoE, and LCAT determined by Western blot analysis of 1 ul of plasma from four
chow-fed WT and ABCA1−A/−A mice. C. Total plasma cholesterol concentration of WT (+/
+; ○) and ABCA1−A/−A (A/−A; ●) mice over 16 wks of HF-diet feeding (2-way ANOVA
with repeated measures; time effect, p<0.0001, genotype effect, p<0.001; n=4 of each
genotype). D. FPLC separation of plasma lipoproteins from WT (+/+; ○) and ABCA1−A/−A
(−A/−A; ●) mice before (chow) and after 2 and 16 wks of HF diet feeding. Each profile
represents a separation of a plasma pool from four mice of each genotype. Lipoprotein
elution was monitored by enzymatic assay of cholesterol in individual fractions (Fr); elution
position of VLDL, LDL, and HDL are indicated in the left panel.
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Figure 4. Deletion of adipocyte ABCA1 does not affect HDL catabolism
A. HDL isolated from WT mice was radiolabeled with 125I-tyramine cellobiose (TC) and
injected into the jugular vein of +/+ (WT; n=4) and −A/−A (ABCA1−A/−A; n=4) recipient
mice. Periodic blood samples over a 24 h time period after injection were withdrawn to
quantify the radioactivity remaining in plasma, normalized to percentage of injected tracer.
B. Twenty-four hr after 125I-TC-HDL tracer injection, mice were sacrificed and liver,
kidney, and epididymal fat (adipose) were removed to quantify tracer uptake by each organ.
Data were normalized to liver uptake in wild type mice.
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Figure 5. Adipocyte ABCA1 generates heterogeneous-sized nascent HDL particles
A. Free cholesterol accumulation in epididymal AT with progressive inactivation of
adipocyte ABCA1 alleles. WT (+/+), heterozygote (−A/+), and homozygote (−A/−A) of
adipocyte-specific ABCA1 knockout mice. B. Cholesterol efflux to apoA-I (ABCA1
dependent) and HDL (ABCA1 independent). Ex vivo cultures of epididymal fat from +/+
and −A/−A mice were radiolabeled with 3H-cholesterol for 24 h, washed, and then
incubated with no addition (no Trt), apoA-I (hAI; 20 ug/ml), or mouse HDL (mHDL; 50 ug/
ml) for 4 hr to measure 3H-FC efflux into the medium. For panels A and B, mean ± SEM,
n=4. * p<0.05, ** p<0.01, ***p<0.001, ns= not significant at p=0.05. C. Nascent HDL
formation in the presence of 125I-apoA-I in ex vivo cultures of epididymal AT from +/+ and
−A/−A mice. After a 24 h incubation, conditioned medium was fractionated by high
resolution FPLC and radiolabeled apoA-I in each fraction was quantified using a gamma
counter. Elution regions for different-sized nascent pre-β HDL particles are denoted by the
vertical dashed lines. Inset shows the size of AT derived-nascent HDLs separated by non-
denaturating gradient gel electrophoresis (4–30%). Migration positions of the radiolabeled
nascent HDL particles were visualized using a phosphorimager.
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